维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Hunsicker L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Aluminum alloys for bearings显示文摘	HUNSICKER H Y KEMPF L W	1947	SAE Quarterly Transactions1947，1，1：	1
2	Renoprotective effect of angiotensin receptor antagonist irbbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis E J Hunsicker L G Clapke W R	2001	N Engl J Med2001，345，：	1
3	Growth of whiskers on Sn-aluminum bearings显示文摘	HUNSICKER H Y KEMPF L W	1947	Q Trans SAE1947，1，：	1
4	The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy显示文摘	Lewis E J Hunsicker L G Bain R P	1993	N Engl J Med1993，329，20：	1
5	Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes : results from the DE- MAND study显示文摘	Dwyer J Parving H Hunsicker L	2012	CardiorenalMed2012，2，：	1
6	A controlled trial of plasmapheresis therapy in severe lupus nephritis:The lupus nephritis collaborative study group显示文摘	Lewis E J Hunsicker L G Lan S P	1992	N Engl J Med1992，326，21：	1
7	Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy显示文摘	Friedman AN Hunsicker LG Selhub L	2002	Diabetes care2002，25，：	1
8	C-reactive Protein as a Predictor of Total Arteriosclerotic Outcomes in Type 2 Diabetic Nephropathy显示文摘	Friedman A N Hunsicker L G Selhub J	2005	Kidney Int2005，68，2：	1
9	The effect of angiot ensinconvert ing enzyme inhibition on diabetic nephropathy显示文摘	Lewis E J Hunsicker L G Bain R P	1993	N Engl J Med1993，329，8：	1
10	Creac- rive protein asap redictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy显示文摘	FRIEDMAN A N HUNSICKER L G SELHUB J	2005	Kidney Int2005，68，2：	1
11	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type2 diabetes显示文摘	LEWIS E J HUNSICKER L G CLARKE W R		0，，12：	1
12	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis E J Hunsicker L G Clarke W R	2001	N Engl J Med2001，345，12：	1
13	Renoprotective effect of the angiotensin-receptor irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	LEWIS E J HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，：	1
14	Emerging trends for prevention and treatment of diabetic nephropathy:blockade of the RAAS and BP control显示文摘	HUNSICKER L G	2004	J Manag Care Pharm2004，10，5：	1
15	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabets显示文摘	LEWIS E J HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，：	1
16	The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy显示文摘	Lewis E J Hunsicker L G Bain R P	1993	N Engl J Med1993，329，：	1
17	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	LWEIS E J HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，12：	1
18	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	l ewis E J Hunsicker LG Clarke WR	2001	N Engl J Med2001，345，12：	1
19	The effect of angiotensin-coverting enzyme inhibition on diabetic nephropathy显示文摘	HUNSICKER L G BAIN RP	1993	N Engl J Med1993，329，：	1
20	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示